Affiliation:
1. Michigan Vascular Institute Birmingham Michigan USA
Abstract
AbstractBackgroundWe previously demonstrated a possible therapeutic benefit of VFEM (variable frequency electromagnetic energy) technology for the treatment of Post Treatment Lyme Disease Syndrome (PTLDS) or Chronic Lyme Disease (CLD). As a result, we prospectively enrolled 10 patients, all having significant debility, to determine to what extent we could improve their quality of life. Eight patients completed the 10 treatments.ResultsAll eight patients had a significant improvement in quality of life within a 4‐month time frame.ConclusionVFEM is a stand‐alone modality that appears to demonstrate a significant improvement in quality of life in PTLDS or CLD with little or no risk or side effects of treatment.